Study Of An FDA-approved Drug As Additional Therapy In Patients With Schizophrenia
Clinical trial NCT00086593 · COMPLETED
Trial details
- NCT number
- NCT00086593
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-05-01
- Primary completion
- 2005-07-01
- Enrollment
- 209
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.